TriMix Laboratories today announced KRS Global Biotechnology has conducted testing on TriMix-gel compounds which allow the expiration date for patient usage to be extended to 60 days. TriMix-gel has ...
TriMix Laboratories announced the launch of TriMix-gel (prostaglandin E, papaverine, phentolamine) for the treatment of erectile dysfunction for patients who cannot tolerate self-injection with a ...
eTheRNA immunotherapies, a clinical-stage company developing mRNA based cancer immunotherapies from its unique TriMix platform, announces the start of the first phase Ib oncology clinical study ...
A 46-year-old man with type II diabetes, hypertension and dyslipidaemia and a 4-year history of erectile dysfunction, presented with a painful priapism 7 h following the administration of oral ...
This article was reviewed by Kelly Brown MD, MBA. For men who don’t respond to oral ED medications like Viagra, Trimix injections can be a game-changer. It’s an injectable ED medication you insert ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback